🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
First line chemotherapy treatment regimens for metastatic colorectal cancer...
Status
Unknown
Location
Associació Catalana per la Recerca Oncològica i les Seves Implicacions Sanitaries i Socials
Start Date
2009-09
Trial ID
NCT01144195
Treatments Being Tested
The primary objective was to describe the pattern of use of panitumumab (Ve...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-10
Trial ID
NCT01732783
Treatments Being Tested
Colorectal cancer (CRC) is a significant and growing health burden in Hong ...
Status
Unknown
Location
Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun
Start Date
2019-01-01
Trial ID
NCT04232748
Treatments Being Tested
This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2022-03-11
Trial ID
NCT05177796
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as panitumumab, can block tumor grow...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
2009-06
Trial ID
NCT00601627
Treatments Being Tested
The purpose of this study is to verify the efficacy of mFOLFOX6 + panitumum...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-29
Trial ID
NCT02394795
The purpose of this study is to assess the pathological response rate in op...
Status
Completed
Location
Centre Jean Perrin
Start Date
2009-09
Trial ID
NCT00933517
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin and fluorouracil, ...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01142414
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-10-19
Trial ID
NCT05863195
This is a three-part study of NUC-3373 administered by intravenous (IV) inf...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2018-10-05
Trial ID
NCT03428958